240 related articles for article (PubMed ID: 18242592)
1. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons.
Hashimoto T; Nishi K; Nagasao J; Tsuji S; Oyanagi K
Brain Res; 2008 Mar; 1197():143-51. PubMed ID: 18242592
[TBL] [Abstract][Full Text] [Related]
2. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
3. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.
Banerjee R; Sreetama S; Saravanan KS; Chandra G; Nath De S; Mohanakumar KP
J Chem Neuroanat; 2006 Dec; 32(2-4):90-100. PubMed ID: 16822645
[TBL] [Abstract][Full Text] [Related]
6. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
7. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
[TBL] [Abstract][Full Text] [Related]
9. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
[TBL] [Abstract][Full Text] [Related]
10. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
Kress GJ; Reynolds IJ
Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
13. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.
Michel PP; Hefti F
J Neurosci Res; 1990 Aug; 26(4):428-35. PubMed ID: 1977925
[TBL] [Abstract][Full Text] [Related]
16. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
17. Gypenosides protects dopaminergic neurons in primary culture against MPP(+)-induced oxidative injury.
Wang P; Niu L; Guo XD; Gao L; Li WX; Jia D; Wang XL; Ma LT; Gao GD
Brain Res Bull; 2010 Oct; 83(5):266-71. PubMed ID: 20615455
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
19. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
[TBL] [Abstract][Full Text] [Related]
20. RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.
Bando Y; Katayama T; Taniguchi M; Ishibashi T; Matsuo N; Ogawa S; Tohyama M
Neurobiol Dis; 2005 Feb; 18(1):143-51. PubMed ID: 15649705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
